Free Trial

3 Mid Caps You Haven't Heard Of But Need To Know About

Mid Cap stocks to buy

Key Points

  • Akero just announced positive updates from a critical trial.
  • C3.ai is on the front-line of the red hot AI industry.
  • Joby is about to move to its commericalization stage with first mover advantage. 
  • 5 stocks we like better than Apple

There have been plenty of headlines in recent weeks regarding the influence a few tech titans are having on the broader market rally that's underway, with some voices suggesting the S&P 500 would actually be down for the year if it were not for their outperformance. 

But that's not to say that there aren't opportunities in stocks outside of powerhouses like Apple Inc NASDAQ: AAPL or Meta Platforms Inc NASDAQ: META. Below are three mid-cap stocks that will not have been on the radar for most readers but whose recent performance warrants closer inspection and consideration. Let's jump in and see why.

Akero Therapeutics, Inc. NASDAQ: AKRO

First up is Akero, a $3 billion biotech based in San Francisco. Like many of their peers, their longer-term chart reflects the ups and downs that more experienced biotech investors will be accustomed to, as unknowable trial results and FDA comments largely dictate how the stock performs. But looking at how Akero's shares have performed in recent sessions, it's easy to tell that a recent catalyst came out on the positive side. 

Akero's shares have jumped as much as 25% since the start of the month after management highlighted the potential of its liver disease therapy. EFX, when used alongside a popular weight loss drug class. Their Phase 2b study showed that EFX combined with GLP-1 led to a 65% reduction in liver fat, compared to a 10% reduction with GLP-1 alone. Safety results were comparable between the groups, and there were no serious adverse events related to the drugs.

Akero has been one of the best-performing mid-caps this week as a result, and while shares cooled somewhat in yesterday's session, they're less than a 10% move from all-time highs. And the best part? Akero has several more key catalysts on the 2023 roadmap that should draw in further volume on the bid. 


C3.ai, Inc. NYSE: AI

Shares of C3.ai have been trading with massive volume in recent weeks, with enough of it on the bid to send them up more than 100% since the start of May. Considering how hot a topic A.I. has suddenly become, it's perhaps not all that surprising. With one of the most market-appropriate tickers in the business, C3.ai is well on its way to reversing the downtrend that's plagued shares since February 2021. 

With a $4 billion market cap, they bill themselves as a leading Enterprise A.I. software provider for accelerating digital transformation, with banner customers such as Shell, Koch, and the U.S. Air Force already signed up. Even with yesterday's 5% dip, the stock is up 250% since the start of the year, and there's every reason to think it will continue to benefit from the red-hot A.I. name. 

Investors looking to gain exposure to a lesser-known but heavily A.I.-focused name could do a lot worse than C3.ai. Look for shares to consolidate in the $30s after their recent rally before pushing on toward $50. Remember, this is a stock that soared to almost $200 during the heady days of 2020, and the wider AI-specific rally is really just starting now.  

Joby Aviation Inc NYSE: JOBY

Last up is Joby, a $4 billion new-age aviation tech company focused on developing electric vertical takeoff and landing aircraft. Their shares have jumped as much as 80% since April, with this week alone seeing gains of more than 10%. 

While much of their work is still in the theoretical and exploratory phase, Joby has already secured contracts with both Toyota and the U.S. Air Force, proving that their path to commercialization is well underway. In fact, their $55 million contract with the latter will see them delivering nine planes starting early next year. 

Last month's additional $180 million raise will have only boosted their R&D capabilities, and they have almost no competitors. This first-mover advantage reminds us of Tesla Inc NASDAQ: TSLA in the electric vehicle space, and we're all familiar with how much of a tailwind that's been for the stock. When it comes to getting in on the ground floor of an industry-defining stock, it doesn't really get much better than this. 

Should you invest $1,000 in Apple right now?

Before you consider Apple, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Apple wasn't on the list.

While Apple currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Energy Stocks to Buy and Hold Forever Cover

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report
Sam Quirke
About The Author

Sam Quirke

Contributing Author

Technical Analysis

Like this article? Share it with a colleague.

Companies Mentioned in This Article

CompanyMarketRank™Current PricePrice ChangeDividend YieldP/E RatioConsensus RatingConsensus Price Target
Akero Therapeutics (AKRO)
4.3473 of 5 stars
4.35 / 5 stars
$26.76-1.2%N/A-8.36Moderate Buy$41.13
Meta Platforms (META)
3.6625 of 5 stars
3.66 / 5 stars
$476.79+0.2%0.42%27.39Moderate Buy$519.10
C3.ai (AI)
3.6843 of 5 stars
3.68 / 5 stars
$27.83-1.5%N/A-11.89Hold$31.30
Tesla (TSLA)
4.4902 of 5 stars
4.49 / 5 stars
$239.20-4.0%N/A61.02Hold$203.03
Joby Aviation (JOBY)
1.1013 of 5 stars
1.10 / 5 stars
$6.54-6.2%N/A-8.60Moderate Buy$7.50
Compare These Stocks  Add These Stocks to My Watchlist 


Featured Articles and Offers

3 Top Market Leaders Splitting Their Stocks

3 Top Market Leaders Splitting Their Stocks

Get an exclusive look at our top three stocks to watch for potential splits.

Related Videos

NVIDIA Tops Microsoft and Apple for Most Valuable Company
3 Strong Buy Stocks for a Summer Surge
Roblox Reality Check: Why the Metaverse Isn’t Saving the Stock!

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines